E
Vaxil Bio Ltd.
VXL.V
TSX
E
Sell
3/11/2025Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 3/11/2025 due to a decline in the volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 3/11/2025 due to a decline in the volatility index.
D
Sell
2/24/2025Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 2/24/2025 due to an increase in the volatility index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 2/24/2025 due to an increase in the volatility index.
E
Sell
5/15/2024Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 5/15/2024 due to a decline in the volatility index and valuation index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 5/15/2024 due to a decline in the volatility index and valuation index.
D
Sell
5/7/2024Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 5/7/2024 due to an increase in the volatility index and total return index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 5/7/2024 due to an increase in the volatility index and total return index.
E
Sell
4/11/2024Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 4/11/2024 due to a decline in the volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 4/11/2024 due to a decline in the volatility index.
D
Sell
3/25/2024Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 3/25/2024 due to an increase in the valuation index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 3/25/2024 due to an increase in the valuation index.
E
Sell
3/6/2024Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 3/6/2024 due to a decline in the volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 3/6/2024 due to a decline in the volatility index.
D
Sell
2/20/2024Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 2/20/2024 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 82.43% from -$207.7 to -$36.5, EBIT increased 73.97% from -$94.5 to -$24.6, and earnings per share increased from -$0.0007 to -$0.0002.
Vaxil Bio Ltd. (VXL.V) was upgraded to D- from E+ on 2/20/2024 due to an increase in the total return index, volatility index and growth index. Operating cash flow increased 82.43% from -$207.7 to -$36.5, EBIT increased 73.97% from -$94.5 to -$24.6, and earnings per share increased from -$0.0007 to -$0.0002.
E
Sell
3/14/2023Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 02/08/2023.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 02/08/2023.
D
Sell
1/4/2023Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index and total return index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index and total return index.
D
Sell
12/12/2022Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 12/12/2022 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.16 to 4.12.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 12/12/2022 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.16 to 4.12.
D
Sell
4/29/2022Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 4/29/2022 due to an increase in the growth index. Operating cash flow increased 55.5% from -$237.3 to -$105.6.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 4/29/2022 due to an increase in the growth index. Operating cash flow increased 55.5% from -$237.3 to -$105.6.
D
Sell
4/20/2022Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, growth index and solvency index. EBIT declined 11.46% from -$170.2 to -$189.7, and earnings per share declined from -$0.0013 to -$0.0014.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, growth index and solvency index. EBIT declined 11.46% from -$170.2 to -$189.7, and earnings per share declined from -$0.0013 to -$0.0014.
D
Sell
11/9/2021Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 11/09/2021.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index, total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index, total return index and volatility index.
D
Sell
5/1/2020Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D from D+ on 5/1/2020 due to a large decline in the total return index and efficiency index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D from D+ on 5/1/2020 due to a large decline in the total return index and efficiency index.
D
Sell
4/30/2020Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D+ from C- on 4/30/2020 due to a significant decline in the efficiency index, solvency index and growth index. Total capital declined 340.4% from -$89.1 to -$392.4, net income declined 137.69% from -$156.8 to -$372.7, and EBIT declined 133.35% from -$156.8 to -$365.9.
Vaxil Bio Ltd. (VXL.V) was downgraded to D+ from C- on 4/30/2020 due to a significant decline in the efficiency index, solvency index and growth index. Total capital declined 340.4% from -$89.1 to -$392.4, net income declined 137.69% from -$156.8 to -$372.7, and EBIT declined 133.35% from -$156.8 to -$365.9.
C
Hold
2/18/2020Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to C- from D+ on 2/18/2020 due to an increase in the total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was upgraded to C- from D+ on 2/18/2020 due to an increase in the total return index and volatility index.
D
Sell
11/29/2019Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D+ from D on 11/29/2019 due to a significant increase in the efficiency index and valuation index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D+ from D on 11/29/2019 due to a significant increase in the efficiency index and valuation index.
D
Sell
8/28/2019Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 8/28/2019 due to an increase in the volatility index and total return index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 8/28/2019 due to an increase in the volatility index and total return index.
E
Sell
5/23/2019Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 5/23/2019 due to a decline in the efficiency index, solvency index and valuation index. Total capital declined 52.55% from $354.7 to $168.3, and the quick ratio declined from 1.78 to 1.41.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 5/23/2019 due to a decline in the efficiency index, solvency index and valuation index. Total capital declined 52.55% from $354.7 to $168.3, and the quick ratio declined from 1.78 to 1.41.
D
Sell
4/24/2019Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 4/24/2019 due to a major decline in the growth index, volatility index and solvency index. Earnings per share declined from -$0.002 to -$0.0035, EBIT declined 72.74% from -$170.6 to -$294.7, and the quick ratio declined from 3.11 to 1.82.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 4/24/2019 due to a major decline in the growth index, volatility index and solvency index. Earnings per share declined from -$0.002 to -$0.0035, EBIT declined 72.74% from -$170.6 to -$294.7, and the quick ratio declined from 3.11 to 1.82.
D
Sell
3/12/2019Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 3/12/2019 due to an increase in the total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 3/12/2019 due to an increase in the total return index and volatility index.
D
Sell
2/21/2019Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 2/21/2019 due to a decline in the valuation index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 2/21/2019 due to a decline in the valuation index.
D
Sell
1/28/2019Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 1/28/2019 due to an increase in the valuation index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 1/28/2019 due to an increase in the valuation index.
D
Sell
1/10/2019Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 1/10/2019 due to a decline in the valuation index, total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 1/10/2019 due to a decline in the valuation index, total return index and volatility index.
D
Sell
11/30/2018Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 11/30/2018 due to an increase in the valuation index and solvency index. The quick ratio increased from 2.54 to 3.11.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from E+ on 11/30/2018 due to an increase in the valuation index and solvency index. The quick ratio increased from 2.54 to 3.11.
E
Sell
8/30/2018Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 8/30/2018 due to a significant decline in the total return index, volatility index and efficiency index. Total capital declined 16.22% from $756.9 to $634.1.
Vaxil Bio Ltd. (VXL.V) was downgraded to E+ from D- on 8/30/2018 due to a significant decline in the total return index, volatility index and efficiency index. Total capital declined 16.22% from $756.9 to $634.1.
D
Sell
6/5/2018Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D+ on 6/5/2018 due to a noticeable decline in the total return index and efficiency index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D+ on 6/5/2018 due to a noticeable decline in the total return index and efficiency index.
D
Sell
4/30/2018Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D+ from D on 4/30/2018 due to a significant increase in the total return index, volatility index and valuation index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D+ from D on 4/30/2018 due to a significant increase in the total return index, volatility index and valuation index.
D
Sell
3/12/2018Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 3/12/2018 due to a noticeable increase in the total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 3/12/2018 due to a noticeable increase in the total return index and volatility index.
D
Sell
2/23/2018Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 2/23/2018 due to a decline in the volatility index and total return index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 2/23/2018 due to a decline in the volatility index and total return index.
D
Sell
2/8/2018Upgraded
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 2/8/2018 due to a noticeable increase in the volatility index and total return index.
Vaxil Bio Ltd. (VXL.V) was upgraded to D from D- on 2/8/2018 due to a noticeable increase in the volatility index and total return index.
D
Sell
11/28/2017Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 11/28/2017 due to a decline in the total return index and volatility index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D- from D on 11/28/2017 due to a decline in the total return index and volatility index.
D
Sell
10/17/2017Downgrade
Vaxil Bio Ltd. (VXL.V) was downgraded to D from D+ on 10/17/2017 due to a major decline in the volatility index, valuation index and total return index.
Vaxil Bio Ltd. (VXL.V) was downgraded to D from D+ on 10/17/2017 due to a major decline in the volatility index, valuation index and total return index.
D
Sell
10/28/2015Upgraded
Emerge Resources Corp. (EME.V) was upgraded to D+ from D on 10/28/2015 due to an increase in the efficiency index, growth index and valuation index. Operating cash flow increased 57.94% from -$35.9 to -$56.7.
Emerge Resources Corp. (EME.V) was upgraded to D+ from D on 10/28/2015 due to an increase in the efficiency index, growth index and valuation index. Operating cash flow increased 57.94% from -$35.9 to -$56.7.
D
Sell
11/11/2014Upgraded
Emerge Resources Corp. (EME.V) was upgraded to D from D- on 11/11/2014 due to an increase in the valuation index, efficiency index and volatility index.
Emerge Resources Corp. (EME.V) was upgraded to D from D- on 11/11/2014 due to an increase in the valuation index, efficiency index and volatility index.
D
Sell
10/10/2014Downgrade
Emerge Resources Corp. (EME.V) was downgraded to D- from D on 10/10/2014 due to a decline in the efficiency index and valuation index. Total capital declined 27.48% from $238.7 to $173.1, and net income declined 22.73% from -$90.2 to -$69.7.
Emerge Resources Corp. (EME.V) was downgraded to D- from D on 10/10/2014 due to a decline in the efficiency index and valuation index. Total capital declined 27.48% from $238.7 to $173.1, and net income declined 22.73% from -$90.2 to -$69.7.
